| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.97e-09 | 20 | 63 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 9.30e-08 | 36 | 63 | 5 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 5.05e-07 | 50 | 63 | 5 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 6.79e-07 | 53 | 63 | 5 | GO:0016859 | |
| GeneOntologyMolecularFunction | NuRD complex binding | 2.93e-05 | 3 | 63 | 2 | GO:0120325 | |
| GeneOntologyMolecularFunction | isomerase activity | 3.15e-05 | 192 | 63 | 6 | GO:0016853 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 2.05e-04 | 656 | 63 | 9 | GO:0008047 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 2.46e-04 | 279 | 63 | 6 | GO:0005096 | |
| GeneOntologyMolecularFunction | actinin binding | 3.38e-04 | 43 | 63 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | nuclear export signal receptor activity | 6.34e-04 | 12 | 63 | 2 | GO:0005049 | |
| GeneOntologyMolecularFunction | GTPase binding | 9.42e-04 | 360 | 63 | 6 | GO:0051020 | |
| GeneOntologyMolecularFunction | muscle alpha-actinin binding | 1.00e-03 | 15 | 63 | 2 | GO:0051371 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 1.06e-03 | 507 | 63 | 7 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 1.06e-03 | 507 | 63 | 7 | GO:0030695 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 2.80e-03 | 25 | 63 | 2 | GO:0017056 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 3.27e-03 | 27 | 63 | 2 | GO:0008139 | |
| GeneOntologyMolecularFunction | small GTPase binding | 3.41e-03 | 321 | 63 | 5 | GO:0031267 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.95e-11 | 20 | 61 | 6 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.39e-11 | 9 | 61 | 5 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.77e-11 | 10 | 61 | 5 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 2.42e-10 | 13 | 61 | 5 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 3.75e-10 | 14 | 61 | 5 | GO:1903299 | |
| GeneOntologyBiologicalProcess | mRNA transport | 4.15e-10 | 145 | 61 | 9 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 2.20e-09 | 175 | 61 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 2.20e-09 | 175 | 61 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 2.56e-09 | 178 | 61 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 3.59e-09 | 185 | 61 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 5.69e-09 | 195 | 61 | 9 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 7.41e-09 | 201 | 61 | 9 | GO:0051170 | |
| GeneOntologyBiologicalProcess | RNA localization | 1.44e-08 | 217 | 61 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 4.73e-08 | 249 | 61 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 8.91e-08 | 38 | 61 | 5 | GO:0000413 | |
| GeneOntologyBiologicalProcess | nuclear transport | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 ADAR RGPD5 | 1.49e-07 | 378 | 61 | 10 | GO:0051169 |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 ADAR RGPD5 | 1.49e-07 | 378 | 61 | 10 | GO:0006913 |
| GeneOntologyBiologicalProcess | protein localization to organelle | RGPD4 RGPD2 RANBP2 HTR2A LHFPL4 RGPD8 NUP98 RGPD1 NUP214 AP4M1 BUB3 ADAR CSRP3 KNL1 RGPD5 | 4.59e-07 | 1091 | 61 | 15 | GO:0033365 |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 5.42e-07 | 54 | 61 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 1.11e-06 | 362 | 61 | 9 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 2.15e-06 | 71 | 61 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 AP4M1 ADAR RGPD5 | 2.48e-06 | 515 | 61 | 10 | GO:0072594 |
| GeneOntologyBiologicalProcess | intracellular protein transport | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 AP4M1 ADAR RGPD5 | 9.57e-06 | 740 | 61 | 11 | GO:0006886 |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.93e-05 | 111 | 61 | 5 | GO:0006094 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 2.29e-05 | 115 | 61 | 5 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 2.93e-05 | 121 | 61 | 5 | GO:0046364 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 4.44e-05 | 132 | 61 | 5 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 4.77e-05 | 134 | 61 | 5 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 6.14e-05 | 231 | 61 | 6 | GO:0006109 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 8.31e-05 | 244 | 61 | 6 | GO:0006006 | |
| GeneOntologyBiologicalProcess | protein localization to juxtaparanode region of axon | 8.55e-05 | 5 | 61 | 2 | GO:0071205 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 1.90e-04 | 284 | 61 | 6 | GO:0019318 | |
| GeneOntologyBiologicalProcess | regulation of small molecule metabolic process | 2.85e-04 | 434 | 61 | 7 | GO:0062012 | |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 3.04e-04 | 310 | 61 | 6 | GO:0005996 | |
| GeneOntologyBiologicalProcess | protein localization to axon | 4.65e-04 | 11 | 61 | 2 | GO:0099612 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription elongation by RNA polymerase II | 5.48e-04 | 54 | 61 | 3 | GO:0032968 | |
| GeneOntologyBiologicalProcess | protein folding | 8.00e-04 | 246 | 61 | 5 | GO:0006457 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 8.15e-04 | 247 | 61 | 5 | GO:0016051 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 8.22e-04 | 62 | 61 | 3 | GO:0032786 | |
| GeneOntologyBiologicalProcess | protein export from nucleus | 9.44e-04 | 65 | 61 | 3 | GO:0006611 | |
| GeneOntologyBiologicalProcess | protein localization to kinetochore | 1.01e-03 | 16 | 61 | 2 | GO:0034501 | |
| GeneOntologyBiologicalProcess | protein localization to condensed chromosome | 1.01e-03 | 16 | 61 | 2 | GO:1903083 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 1.18e-03 | 156 | 61 | 4 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 1.18e-03 | 156 | 61 | 4 | GO:0010927 | |
| GeneOntologyBiologicalProcess | intracellular transport | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 FNBP1L AP4M1 ADAR RGPD5 | 1.27e-03 | 1496 | 61 | 12 | GO:0046907 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.22e-13 | 10 | 63 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear pore | RGPD4 PARP11 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 RGPD5 | 4.54e-13 | 101 | 63 | 10 | GO:0005643 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.06e-11 | 18 | 63 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.18e-11 | 8 | 63 | 5 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.20e-11 | 20 | 63 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | annulate lamellae | 4.15e-10 | 14 | 63 | 5 | GO:0005642 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 4.15e-09 | 21 | 63 | 5 | GO:0106068 | |
| GeneOntologyCellularComponent | inclusion body | 3.00e-07 | 90 | 63 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 CCNT1 PARP11 TTF2 RGPD2 LIG3 RANBP2 ATRIP RGPD8 NUP98 RGPD1 KMT2A NUP214 NUP42 BUB3 ADAR RGPD5 | 4.18e-07 | 1377 | 63 | 17 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear envelope | RGPD4 PARP11 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 RGPD5 | 6.27e-06 | 560 | 63 | 10 | GO:0005635 |
| GeneOntologyCellularComponent | nuclear membrane | 8.44e-05 | 349 | 63 | 7 | GO:0031965 | |
| GeneOntologyCellularComponent | juxtaparanode region of axon | 5.79e-04 | 12 | 63 | 2 | GO:0044224 | |
| GeneOntologyCellularComponent | paranode region of axon | 1.18e-03 | 17 | 63 | 2 | GO:0033270 | |
| GeneOntologyCellularComponent | axolemma | 1.81e-03 | 21 | 63 | 2 | GO:0030673 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.20e-11 | 16 | 50 | 6 | MP:0003701 | |
| MousePheno | abnormal morula morphology | 2.96e-08 | 26 | 50 | 5 | MP:0012058 | |
| MousePheno | decreased tumor latency | 6.35e-08 | 30 | 50 | 5 | MP:0010308 | |
| MousePheno | aneuploidy | 7.35e-08 | 61 | 50 | 6 | MP:0004024 | |
| MousePheno | failure of blastocyst formation | 7.55e-08 | 31 | 50 | 5 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 1.23e-07 | 34 | 50 | 5 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 2.50e-07 | 39 | 50 | 5 | MP:0012128 | |
| MousePheno | abnormal mitosis | 3.30e-07 | 128 | 50 | 7 | MP:0004046 | |
| MousePheno | abnormal chromosome number | 5.81e-07 | 86 | 50 | 6 | MP:0004023 | |
| MousePheno | increased incidence of tumors by chemical induction | 6.36e-07 | 141 | 50 | 7 | MP:0004499 | |
| MousePheno | increased incidence of induced tumors | 2.51e-06 | 173 | 50 | 7 | MP:0002021 | |
| MousePheno | increased hepatocellular carcinoma incidence | 4.84e-06 | 70 | 50 | 5 | MP:0003331 | |
| MousePheno | abnormal chromosome morphology | 5.47e-06 | 126 | 50 | 6 | MP:0003702 | |
| MousePheno | abnormal preimplantation embryo morphology | 6.56e-06 | 283 | 50 | 8 | MP:0014137 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 7.23e-06 | 203 | 50 | 7 | MP:0011094 | |
| MousePheno | increased lung carcinoma incidence | 8.27e-06 | 78 | 50 | 5 | MP:0008714 | |
| MousePheno | embryonic lethality prior to organogenesis, complete penetrance | RGPD4 RGPD2 RANBP2 RGPD8 PI4KA RGPD1 HLCS KMT2A NUP214 REV3L BUB3 KNL1 | 1.28e-05 | 772 | 50 | 12 | MP:0014259 |
| MousePheno | embryonic lethality prior to tooth bud stage, complete penetrance | RGPD4 RGPD2 RANBP2 RGPD8 PI4KA RGPD1 HLCS KMT2A NUP214 REV3L BUB3 KNL1 | 1.41e-05 | 779 | 50 | 12 | MP:0014257 |
| MousePheno | increased malignant tumor incidence | 1.98e-05 | 237 | 50 | 7 | MP:0002018 | |
| MousePheno | decreased susceptibility to diet-induced obesity | 2.15e-05 | 160 | 50 | 6 | MP:0005659 | |
| MousePheno | embryonic lethality before implantation | 2.26e-05 | 242 | 50 | 7 | MP:0006204 | |
| MousePheno | enlarged epididymis | 2.65e-05 | 99 | 50 | 5 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 3.06e-05 | 102 | 50 | 5 | MP:0002032 | |
| MousePheno | increased lung tumor incidence | 3.85e-05 | 107 | 50 | 5 | MP:0008014 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 3.85e-05 | 107 | 50 | 5 | MP:0003694 | |
| MousePheno | increased respiratory system tumor incidence | 3.85e-05 | 107 | 50 | 5 | MP:0010298 | |
| MousePheno | impaired glucose tolerance | 4.40e-05 | 480 | 50 | 9 | MP:0005293 | |
| MousePheno | abnormal incidence of induced tumors | 4.45e-05 | 269 | 50 | 7 | MP:0013151 | |
| MousePheno | increased liver tumor incidence | 4.60e-05 | 111 | 50 | 5 | MP:0008019 | |
| MousePheno | increased hepatobiliary system tumor incidence | 4.60e-05 | 111 | 50 | 5 | MP:0010297 | |
| MousePheno | abnormal cell nucleus morphology | 4.71e-05 | 184 | 50 | 6 | MP:0003111 | |
| MousePheno | decreased susceptibility to weight gain | 5.00e-05 | 186 | 50 | 6 | MP:0010182 | |
| MousePheno | abnormal blastocyst hatching | 5.01e-05 | 113 | 50 | 5 | MP:0003693 | |
| MousePheno | embryonic lethality prior to organogenesis | RGPD4 RGPD2 LIG3 RANBP2 ATRIP RGPD8 PI4KA RGPD1 HLCS KMT2A NUP214 REV3L BUB3 KNL1 | 5.59e-05 | 1204 | 50 | 14 | MP:0013292 |
| MousePheno | abnormal embryo development | RGPD4 TMEM67 RGPD2 LIG3 RANBP2 ERF RGPD8 NUP98 RGPD1 HLCS KMT2A PPARD REV3L ADAR TOP2B | 5.63e-05 | 1370 | 50 | 15 | MP:0001672 |
| MousePheno | embryonic lethality prior to tooth bud stage | RGPD4 RGPD2 LIG3 RANBP2 ERF ATRIP RGPD8 PI4KA RGPD1 HLCS KMT2A NUP214 REV3L BUB3 KNL1 | 6.29e-05 | 1383 | 50 | 15 | MP:0013293 |
| MousePheno | abnormal rod electrophysiology | 6.41e-05 | 119 | 50 | 5 | MP:0004021 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 6.56e-05 | 286 | 50 | 7 | MP:0008873 | |
| MousePheno | increased energy expenditure | 6.69e-05 | 196 | 50 | 6 | MP:0004889 | |
| MousePheno | increased carcinoma incidence | 6.88e-05 | 197 | 50 | 6 | MP:0002038 | |
| MousePheno | abnormal energy expenditure | 1.15e-04 | 313 | 50 | 7 | MP:0005450 | |
| MousePheno | abnormal intracellular organelle morphology | 1.19e-04 | 546 | 50 | 9 | MP:0014239 | |
| MousePheno | abnormal energy homeostasis | 1.38e-04 | 322 | 50 | 7 | MP:0005448 | |
| MousePheno | abnormal eye electrophysiology | 1.54e-04 | 228 | 50 | 6 | MP:0005551 | |
| MousePheno | abnormal epididymis size | 3.06e-04 | 166 | 50 | 5 | MP:0004926 | |
| MousePheno | abnormal preimplantation embryo development | 3.51e-04 | 171 | 50 | 5 | MP:0009781 | |
| MousePheno | increased classified tumor incidence | 3.84e-04 | 381 | 50 | 7 | MP:0010273 | |
| MousePheno | abnormal glucose tolerance | RGPD4 PRSS35 RGPD2 RANBP2 PWWP2B RGPD8 RGPD1 ITPRID2 PPARD KNL1 | 3.98e-04 | 787 | 50 | 10 | MP:0005291 |
| MousePheno | abnormal classified tumor incidence | 4.03e-04 | 384 | 50 | 7 | MP:0020188 | |
| MousePheno | abnormal cell cycle | 4.70e-04 | 520 | 50 | 8 | MP:0003077 | |
| MousePheno | increased organ/body region tumor incidence | 4.77e-04 | 395 | 50 | 7 | MP:0010274 | |
| MousePheno | abnormal organ/body region tumor incidence | 5.22e-04 | 401 | 50 | 7 | MP:0013152 | |
| MousePheno | increased tumor incidence | 5.34e-04 | 530 | 50 | 8 | MP:0002020 | |
| MousePheno | decreased hindbrain size | 5.54e-04 | 10 | 50 | 2 | MP:0012263 | |
| MousePheno | abnormal susceptibility to weight gain | 7.79e-04 | 309 | 50 | 6 | MP:0011117 | |
| MousePheno | abnormal hindbrain size | 9.54e-04 | 13 | 50 | 2 | MP:0012262 | |
| MousePheno | neoplasm | 1.18e-03 | 747 | 50 | 9 | MP:0002006 | |
| MousePheno | abnormal eye physiology | 1.28e-03 | 606 | 50 | 8 | MP:0005253 | |
| MousePheno | abnormal tumor incidence | 1.72e-03 | 635 | 50 | 8 | MP:0002019 | |
| MousePheno | abnormal compact bone volume | 1.85e-03 | 18 | 50 | 2 | MP:0010963 | |
| MousePheno | abnormal tumor susceptibility | 1.99e-03 | 650 | 50 | 8 | MP:0002166 | |
| Domain | Ran_BP1 | 8.58e-13 | 12 | 61 | 6 | PF00638 | |
| Domain | RANBD1 | 8.58e-13 | 12 | 61 | 6 | PS50196 | |
| Domain | RanBD | 1.59e-12 | 13 | 61 | 6 | SM00160 | |
| Domain | Ran_bind_dom | 1.59e-12 | 13 | 61 | 6 | IPR000156 | |
| Domain | Grip | 1.43e-10 | 11 | 61 | 5 | SM00755 | |
| Domain | GRIP | 1.43e-10 | 11 | 61 | 5 | PF01465 | |
| Domain | GRIP_dom | 2.45e-10 | 12 | 61 | 5 | IPR000237 | |
| Domain | GRIP | 2.45e-10 | 12 | 61 | 5 | PS50913 | |
| Domain | GCC2_Rab_bind | 3.58e-09 | 7 | 61 | 4 | IPR032023 | |
| Domain | Rab_bind | 3.58e-09 | 7 | 61 | 4 | PF16704 | |
| Domain | - | 2.13e-08 | 10 | 61 | 4 | 1.10.220.60 | |
| Domain | TPR-contain_dom | 9.37e-06 | 150 | 61 | 6 | IPR013026 | |
| Domain | TPR_REGION | 1.61e-05 | 165 | 61 | 6 | PS50293 | |
| Domain | TPR | 1.61e-05 | 165 | 61 | 6 | PS50005 | |
| Domain | TPR | 6.35e-05 | 129 | 61 | 5 | SM00028 | |
| Domain | PH_dom-like | 7.01e-05 | 426 | 61 | 8 | IPR011993 | |
| Domain | TPR_repeat | 7.34e-05 | 133 | 61 | 5 | IPR019734 | |
| Domain | TPR-like_helical_dom | 1.11e-04 | 233 | 61 | 6 | IPR011990 | |
| Domain | TPR_1 | 2.13e-04 | 90 | 61 | 4 | PF00515 | |
| Domain | TPR_1 | 2.13e-04 | 90 | 61 | 4 | IPR001440 | |
| Domain | - | 2.75e-04 | 391 | 61 | 7 | 2.30.29.30 | |
| Domain | VIT | 4.64e-04 | 10 | 61 | 2 | PS51468 | |
| Domain | VIT | 4.64e-04 | 10 | 61 | 2 | IPR013694 | |
| Domain | - | 5.73e-04 | 207 | 61 | 5 | 1.25.40.10 | |
| Domain | PWWP | 1.92e-03 | 20 | 61 | 2 | SM00293 | |
| Domain | PWWP | 2.54e-03 | 23 | 61 | 2 | PF00855 | |
| Domain | PWWP_dom | 2.54e-03 | 23 | 61 | 2 | IPR000313 | |
| Domain | PWWP | 2.77e-03 | 24 | 61 | 2 | PS50812 | |
| Domain | ETS_DOMAIN_1 | 3.76e-03 | 28 | 61 | 2 | PS00345 | |
| Domain | ETS_DOMAIN_2 | 3.76e-03 | 28 | 61 | 2 | PS00346 | |
| Domain | ETS | 3.76e-03 | 28 | 61 | 2 | SM00413 | |
| Domain | Ets_dom | 3.76e-03 | 28 | 61 | 2 | IPR000418 | |
| Domain | ETS_DOMAIN_3 | 3.76e-03 | 28 | 61 | 2 | PS50061 | |
| Domain | Ets | 3.76e-03 | 28 | 61 | 2 | PF00178 | |
| Domain | - | 5.60e-03 | 218 | 61 | 4 | 1.10.10.10 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.05e-14 | 51 | 42 | 9 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 2.20e-13 | 40 | 42 | 8 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.72e-13 | 41 | 42 | 8 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.35e-13 | 42 | 42 | 8 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.11e-13 | 43 | 42 | 8 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 8.84e-13 | 47 | 42 | 8 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.26e-12 | 49 | 42 | 8 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.50e-12 | 50 | 42 | 8 | MM14610 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 3.37e-12 | 55 | 42 | 8 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 5.26e-12 | 58 | 42 | 8 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 5.26e-12 | 58 | 42 | 8 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.37e-11 | 65 | 42 | 8 | MM15147 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.57e-11 | 73 | 42 | 8 | MM14948 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 9.29e-11 | 82 | 42 | 8 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 1.13e-10 | 84 | 42 | 8 | MM14929 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.37e-10 | 86 | 42 | 8 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.38e-10 | 92 | 42 | 8 | MM14951 | |
| Pathway | REACTOME_SUMOYLATION | 1.31e-09 | 169 | 42 | 9 | MM14919 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 1.34e-09 | 114 | 42 | 8 | MM15361 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.53e-09 | 18 | 42 | 5 | MM1549 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.61e-08 | 100 | 42 | 7 | MM14561 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 4.80e-08 | 117 | 42 | 7 | MM15387 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 9.43e-08 | 129 | 42 | 7 | MM14894 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.74e-07 | 141 | 42 | 7 | MM15266 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.30e-07 | 46 | 42 | 5 | M27397 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.13e-06 | 271 | 42 | 8 | MM15388 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.13e-06 | 271 | 42 | 8 | MM15406 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 1.33e-06 | 277 | 42 | 8 | MM15414 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 1.45e-06 | 193 | 42 | 7 | MM14890 | |
| Pathway | REACTOME_M_PHASE | 1.61e-06 | 387 | 42 | 9 | MM15364 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | RGPD4 RGPD2 RANBP2 ERF RGPD8 SLC38A9 NUP98 RGPD1 NUP214 NUP42 | 1.67e-06 | 505 | 42 | 10 | MM15548 |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.97e-06 | 202 | 42 | 7 | MM15362 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 2.30e-06 | 32 | 42 | 4 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.62e-06 | 33 | 42 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 2.96e-06 | 34 | 42 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.33e-06 | 35 | 42 | 4 | M27320 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 3.74e-06 | 36 | 42 | 4 | M27245 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 3.74e-06 | 36 | 42 | 4 | M26974 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 4.19e-06 | 37 | 42 | 4 | M1029 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 4.19e-06 | 37 | 42 | 4 | M27038 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | RGPD4 CCNT1 RGPD2 RANBP2 ATRIP RGPD8 SLC38A9 NUP98 RGPD1 KMT2A NUP214 NUP42 PPARD | 4.98e-06 | 1022 | 42 | 13 | MM15436 |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 5.19e-06 | 39 | 42 | 4 | M27238 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 5.22e-06 | 234 | 42 | 7 | MM14898 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 6.36e-06 | 41 | 42 | 4 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 7.72e-06 | 43 | 42 | 4 | M26975 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RGPD2 RANBP2 ATRIP RGPD8 NUP98 RGPD1 NUP214 NUP42 BUB3 | 8.10e-06 | 603 | 42 | 10 | MM14635 |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 8.47e-06 | 44 | 42 | 4 | M109 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 9.65e-06 | 257 | 42 | 7 | MM14755 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.11e-05 | 47 | 42 | 4 | M27395 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.79e-05 | 53 | 42 | 4 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.93e-05 | 54 | 42 | 4 | M29594 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 2.75e-05 | 59 | 42 | 4 | M27606 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 4.14e-05 | 131 | 42 | 5 | M5283 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 5.72e-05 | 71 | 42 | 4 | M27394 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 6.36e-05 | 612 | 42 | 9 | MM15547 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 6.73e-05 | 74 | 42 | 4 | M48006 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 7.66e-05 | 149 | 42 | 5 | M4076 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 7.87e-05 | 77 | 42 | 4 | M27226 | |
| Pathway | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | 8.15e-05 | 151 | 42 | 5 | M550 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.01e-04 | 82 | 42 | 4 | M27250 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 1.10e-04 | 84 | 42 | 4 | M725 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.16e-04 | 85 | 42 | 4 | M1870 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 2.09e-04 | 99 | 42 | 4 | M27474 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 2.25e-04 | 101 | 42 | 4 | M27253 | |
| Pathway | REACTOME_SUMOYLATION | 2.34e-04 | 189 | 42 | 5 | M27214 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 2.71e-04 | 106 | 42 | 4 | M27458 | |
| Pathway | WP_PRADERWILLI_AND_ANGELMAN_SYNDROME | 3.02e-04 | 109 | 42 | 4 | M39542 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 3.24e-04 | 111 | 42 | 4 | M27673 | |
| Pathway | REACTOME_TRNA_PROCESSING | 3.24e-04 | 111 | 42 | 4 | M27684 | |
| Pathway | REACTOME_HCMV_LATE_EVENTS | 3.83e-04 | 116 | 42 | 4 | M29806 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC | 3.84e-04 | 10 | 42 | 2 | M47886 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 4.69e-04 | 11 | 42 | 2 | M22033 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 5.24e-04 | 126 | 42 | 4 | M45009 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.40e-04 | 127 | 42 | 4 | M27181 | |
| Pathway | REACTOME_HIV_INFECTION | 5.87e-04 | 231 | 42 | 5 | M12469 | |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | 7.37e-04 | 138 | 42 | 4 | M29805 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 7.58e-04 | 139 | 42 | 4 | M715 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 7.78e-04 | 140 | 42 | 4 | M27550 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 8.21e-04 | 142 | 42 | 4 | M27660 | |
| Pathway | REACTOME_INFLUENZA_INFECTION | 1.19e-03 | 157 | 42 | 4 | M4669 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 1.24e-03 | 273 | 42 | 5 | M983 | |
| Pathway | REACTOME_HCMV_INFECTION | 1.34e-03 | 162 | 42 | 4 | M29804 | |
| Pathway | REACTOME_M_PHASE | 1.38e-03 | 417 | 42 | 6 | M27662 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | 1.65e-03 | 291 | 42 | 5 | M16647 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 1.85e-03 | 177 | 42 | 4 | M27476 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 2.44e-03 | 191 | 42 | 4 | M29614 | |
| Pathway | KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION | 2.69e-03 | 26 | 42 | 2 | M47439 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.81e-03 | 649 | 42 | 7 | MM15690 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 3.10e-03 | 204 | 42 | 4 | M45011 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 3.10e-03 | 204 | 42 | 4 | M4217 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA | 3.58e-03 | 30 | 42 | 2 | M47752 | |
| Pathway | REACTOME_CELL_CYCLE | 4.07e-03 | 694 | 42 | 7 | M543 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 5.21e-03 | 236 | 42 | 4 | M27185 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | 5.99e-03 | 561 | 42 | 6 | M5336 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 NUP214 NUP42 MUC1 TOP2B | 6.51e-03 | 1389 | 42 | 10 | MM15307 |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.81e-15 | 9 | 65 | 6 | 18394993 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 4.45e-15 | 38 | 65 | 8 | 12791264 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.71e-14 | 13 | 65 | 6 | 31427429 | |
| Pubmed | 1.66e-13 | 15 | 65 | 6 | 14697343 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 21205196 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 18949001 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 25187515 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 9037092 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 8603673 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 4.08e-13 | 7 | 65 | 5 | 15710750 | |
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 26632511 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 24403063 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 23818861 | ||
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 4.08e-13 | 7 | 65 | 5 | 11353387 | |
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 30944974 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 38838144 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 23536549 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 4.08e-13 | 7 | 65 | 5 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 4.08e-13 | 7 | 65 | 5 | 17372272 | |
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 38657106 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 12191015 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 22821000 | ||
| Pubmed | 4.08e-13 | 7 | 65 | 5 | 20682751 | ||
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 1.09e-12 | 8 | 65 | 5 | 22262462 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 1.09e-12 | 8 | 65 | 5 | 21670213 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 1.09e-12 | 8 | 65 | 5 | 28745977 | |
| Pubmed | 1.09e-12 | 8 | 65 | 5 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 1.09e-12 | 8 | 65 | 5 | 21310149 | |
| Pubmed | 2.44e-12 | 9 | 65 | 5 | 11553612 | ||
| Pubmed | 2.44e-12 | 9 | 65 | 5 | 10601307 | ||
| Pubmed | 2.44e-12 | 9 | 65 | 5 | 9733766 | ||
| Pubmed | 2.44e-12 | 9 | 65 | 5 | 28100513 | ||
| Pubmed | 2.44e-12 | 9 | 65 | 5 | 28877029 | ||
| Pubmed | 2.44e-12 | 9 | 65 | 5 | 17887960 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 4.87e-12 | 10 | 65 | 5 | 8857542 | |
| Pubmed | 4.87e-12 | 10 | 65 | 5 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 4.87e-12 | 10 | 65 | 5 | 16332688 | |
| Pubmed | 4.87e-12 | 10 | 65 | 5 | 21859863 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 8.92e-12 | 11 | 65 | 5 | 35771867 | |
| Pubmed | 8.92e-12 | 11 | 65 | 5 | 17069463 | ||
| Pubmed | 8.92e-12 | 11 | 65 | 5 | 34110283 | ||
| Pubmed | 2.64e-10 | 215 | 65 | 9 | 35973513 | ||
| Pubmed | 2.73e-10 | 86 | 65 | 7 | 37253089 | ||
| Pubmed | 5.01e-10 | 22 | 65 | 5 | 27717094 | ||
| Pubmed | 1.22e-08 | 40 | 65 | 5 | 37516964 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | CCNT1 TTF2 LIG3 RANBP2 NUP98 HLCS KMT2A NUP214 EPB41L3 ADAR PALLD TOP2B KNL1 | 1.57e-08 | 934 | 65 | 13 | 33916271 |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 9480752 | ||
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 3.00e-08 | 370 | 65 | 9 | 22922362 | |
| Pubmed | 6.21e-08 | 5 | 65 | 3 | 19828735 | ||
| Pubmed | 8.47e-08 | 418 | 65 | 9 | 34709266 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 1.21e-07 | 123 | 65 | 6 | 26912792 | |
| Pubmed | Karyopherin beta2 mediates nuclear import of a mRNA binding protein. | 1.24e-07 | 6 | 65 | 3 | 9144189 | |
| Pubmed | 1.36e-07 | 25 | 65 | 4 | 10601273 | ||
| Pubmed | 1.61e-07 | 26 | 65 | 4 | 12228227 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 2.09e-07 | 135 | 65 | 6 | 31077711 | |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 2.25e-07 | 226 | 65 | 7 | 37839992 | |
| Pubmed | Imaging within single NPCs reveals NXF1's role in mRNA export on the cytoplasmic side of the pore. | 3.47e-07 | 8 | 65 | 3 | 31375530 | |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 KMT2A CEP295 FNBP1L ITIH6 EPB41L3 TOP2B CUX1 RGPD5 | 3.50e-07 | 1442 | 65 | 14 | 35575683 | |
| Pubmed | 5.19e-07 | 9 | 65 | 3 | 9114010 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | PWWP2A TTF2 LIG3 RANBP2 ERF NUP98 KMT2A ELF4 NUP214 BUB3 ADAR TOP2B CUX1 | 6.69e-07 | 1294 | 65 | 13 | 30804502 |
| Pubmed | 1.22e-06 | 99 | 65 | 5 | 27746211 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CCNT1 LIG3 RANBP2 NUP98 KMT2A NUP214 EPB41L3 ADAR TOP2B CUX1 KNL1 | 1.45e-06 | 954 | 65 | 11 | 36373674 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | 2.44e-06 | 626 | 65 | 9 | 33644029 | |
| Pubmed | HIV integration targeting: a pathway involving Transportin-3 and the nuclear pore protein RanBP2. | 3.44e-06 | 2 | 65 | 2 | 21423673 | |
| Pubmed | Characterization of the MLL partner gene AF15q14 involved in t(11;15)(q23;q14). | 3.44e-06 | 2 | 65 | 2 | 12618768 | |
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 30962003 | ||
| Pubmed | 3.44e-06 | 2 | 65 | 2 | 20558618 | ||
| Pubmed | 3.45e-06 | 486 | 65 | 8 | 20936779 | ||
| Pubmed | 3.75e-06 | 660 | 65 | 9 | 32780723 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 4.12e-06 | 857 | 65 | 10 | 25609649 | |
| Pubmed | 4.16e-06 | 17 | 65 | 3 | 10668806 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 4.23e-06 | 351 | 65 | 7 | 38297188 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 4.79e-06 | 231 | 65 | 6 | 16452087 | |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 8.21e-06 | 146 | 65 | 5 | 23892456 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.03e-05 | 153 | 65 | 5 | 26365490 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 28392395 | ||
| Pubmed | NUP98 Fusion Proteins Interact with the NSL and MLL1 Complexes to Drive Leukemogenesis. | 1.03e-05 | 3 | 65 | 2 | 27889185 | |
| Pubmed | Sequential multisite phospho-regulation of KNL1-BUB3 interfaces at mitotic kinetochores. | 1.03e-05 | 3 | 65 | 2 | 25661489 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 28210005 | ||
| Pubmed | Organization of myelinated axons by Caspr and Caspr2 requires the cytoskeletal adapter protein 4.1B. | 1.03e-05 | 3 | 65 | 2 | 20164332 | |
| Pubmed | A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene MPFYVE on chromosome 15. | 1.03e-05 | 3 | 65 | 2 | 12618766 | |
| Pubmed | The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML. | 1.03e-05 | 3 | 65 | 2 | 34582559 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 9847314 | ||
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 12589057 | ||
| Pubmed | The nuclear pore complex: a new dynamic in HIV-1 replication. | 1.03e-05 | 3 | 65 | 2 | 21327100 | |
| Pubmed | 1.03e-05 | 3 | 65 | 2 | 8943370 | ||
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 PI4KA RGPD1 BUB3 EPB41L3 TENM2 CUX1 | 1.14e-05 | 963 | 65 | 10 | 28671696 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 1.19e-05 | 271 | 65 | 6 | 32433965 | |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.36e-05 | 77 | 65 | 4 | 24927568 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | 1.88e-05 | 442 | 65 | 7 | 15815621 | |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.94e-05 | 444 | 65 | 7 | 34795231 | |
| Pubmed | Kinetochore scaffold 1 regulates SAC function during mouse oocyte meiotic maturation. | 2.06e-05 | 4 | 65 | 2 | 35167144 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 9368759 | ||
| Pubmed | Structural and functional analysis of mRNA export regulation by the nuclear pore complex. | 2.06e-05 | 4 | 65 | 2 | 29899397 | |
| Pubmed | A new nucleoporin-like protein interacts with both HIV-1 Rev nuclear export signal and CRM-1. | 2.06e-05 | 4 | 65 | 2 | 10358091 | |
| Pubmed | SET-NUP214 and MLL cooperatively regulate the promoter activity of the HoxA10 gene. | 2.06e-05 | 4 | 65 | 2 | 34320268 | |
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 12542678 | ||
| Pubmed | 2.06e-05 | 4 | 65 | 2 | 30228260 | ||
| Pubmed | Defining the molecular basis of BubR1 kinetochore interactions and APC/C-CDC20 inhibition. | 2.06e-05 | 4 | 65 | 2 | 20220147 | |
| Pubmed | In vitro analysis of nuclear transport mediated by the C-terminal shuttle domain of Tap. | 2.06e-05 | 4 | 65 | 2 | 11551912 | |
| Interaction | RGPD4 interactions | 4.75e-11 | 22 | 62 | 6 | int:RGPD4 | |
| Interaction | RGPD1 interactions | 1.43e-10 | 49 | 62 | 7 | int:RGPD1 | |
| Interaction | RGPD2 interactions | 1.86e-10 | 27 | 62 | 6 | int:RGPD2 | |
| Interaction | NUP43 interactions | LIG3 RANBP2 ERF RGPD8 PI4KA NUP98 KMT2A ELF4 NUP214 ITPRID2 NUP42 TOP2B KNL1 RGPD5 | 4.85e-09 | 625 | 62 | 14 | int:NUP43 |
| Interaction | RGPD3 interactions | 6.44e-09 | 47 | 62 | 6 | int:RGPD3 | |
| Interaction | RANBP2 interactions | RGPD4 RGPD2 RANBP2 RGPD8 CNTNAP2 NUP98 RGPD1 NUP214 ADAR TOP2B RGPD5 | 1.18e-08 | 361 | 62 | 11 | int:RANBP2 |
| Interaction | RGPD8 interactions | 1.04e-07 | 74 | 62 | 6 | int:RGPD8 | |
| Interaction | NPIPB6 interactions | 2.41e-07 | 18 | 62 | 4 | int:NPIPB6 | |
| Interaction | RGPD5 interactions | 4.95e-07 | 96 | 62 | 6 | int:RGPD5 | |
| Interaction | NUMA1 interactions | PWWP2A LIG3 RANBP2 NUP98 KMT2A NUP214 NUP42 EPB41L3 ADAR TOP2B | 1.54e-06 | 469 | 62 | 10 | int:NUMA1 |
| Interaction | RAN interactions | RGPD4 RGPD2 RANBP2 RGPD8 NUP98 RGPD1 KMT2A NUP214 NUP42 RGPD5 | 1.73e-06 | 475 | 62 | 10 | int:RAN |
| Interaction | NAA40 interactions | CCNT1 TTF2 LIG3 RANBP2 NUP98 HLCS KMT2A NUP214 EPB41L3 ADAR PALLD TOP2B KNL1 | 6.93e-06 | 978 | 62 | 13 | int:NAA40 |
| Interaction | NUP62 interactions | 2.02e-05 | 273 | 62 | 7 | int:NUP62 | |
| Interaction | NUP214 interactions | 2.98e-05 | 195 | 62 | 6 | int:NUP214 | |
| Interaction | MLLT1 interactions | 3.82e-05 | 123 | 62 | 5 | int:MLLT1 | |
| Interaction | CRYBB3 interactions | 4.22e-05 | 63 | 62 | 4 | int:CRYBB3 | |
| Interaction | SMC5 interactions | CCNT1 LIG3 RANBP2 NUP98 KMT2A NUP214 REV3L EPB41L3 ADAR TOP2B CUX1 KNL1 | 4.52e-05 | 1000 | 62 | 12 | int:SMC5 |
| Interaction | NXF2 interactions | 4.78e-05 | 65 | 62 | 4 | int:NXF2 | |
| Interaction | CXXC1 interactions | 5.36e-05 | 132 | 62 | 5 | int:CXXC1 | |
| Interaction | DPPA3 interactions | 5.38e-05 | 67 | 62 | 4 | int:DPPA3 | |
| Interaction | NUP107 interactions | 5.99e-05 | 221 | 62 | 6 | int:NUP107 | |
| Interaction | FOXD3 interactions | 8.60e-05 | 28 | 62 | 3 | int:FOXD3 | |
| Interaction | RICTOR interactions | RGPD4 CCNT1 RGPD2 RGPD8 RGPD1 NUP214 PPARD EPB41L3 CUX1 RGPD5 | 9.87e-05 | 759 | 62 | 10 | int:RICTOR |
| Interaction | PML interactions | CCNT1 LIG3 RANBP2 KMT2A ELF4 FNBP1L BUB3 EPB41L3 PALLD TOP2B KNL1 | 1.15e-04 | 933 | 62 | 11 | int:PML |
| Interaction | HDAC1 interactions | PWWP2A RANBP2 PWWP2B NUP98 KMT2A NUP214 PPARD BUB3 EPB41L3 TOP2B CUX1 KNL1 | 1.21e-04 | 1108 | 62 | 12 | int:HDAC1 |
| Interaction | TRAF3IP3 interactions | 1.30e-04 | 84 | 62 | 4 | int:TRAF3IP3 | |
| Interaction | NEMP1 interactions | 1.63e-04 | 89 | 62 | 4 | int:NEMP1 | |
| Interaction | NUP58 interactions | 1.85e-04 | 92 | 62 | 4 | int:NUP58 | |
| Interaction | APC interactions | 1.87e-04 | 389 | 62 | 7 | int:APC | |
| Interaction | JTB interactions | 2.17e-04 | 38 | 62 | 3 | int:JTB | |
| Interaction | NUPR1 interactions | 2.28e-04 | 683 | 62 | 9 | int:NUPR1 | |
| Interaction | AMZ1 interactions | 3.36e-04 | 44 | 62 | 3 | int:AMZ1 | |
| Interaction | FOXL1 interactions | 3.41e-04 | 196 | 62 | 5 | int:FOXL1 | |
| Interaction | RCC1 interactions | 3.83e-04 | 201 | 62 | 5 | int:RCC1 | |
| Interaction | LRRC31 interactions | 4.19e-04 | 205 | 62 | 5 | int:LRRC31 | |
| Interaction | PPARD interactions | 4.64e-04 | 117 | 62 | 4 | int:PPARD | |
| Interaction | RANBP1 interactions | 4.78e-04 | 211 | 62 | 5 | int:RANBP1 | |
| Interaction | RPS6KL1 interactions | 5.20e-04 | 51 | 62 | 3 | int:RPS6KL1 | |
| Interaction | NUP153 interactions | 5.32e-04 | 216 | 62 | 5 | int:NUP153 | |
| Interaction | NUP98 interactions | 5.78e-04 | 220 | 62 | 5 | int:NUP98 | |
| Interaction | TENM2 interactions | 6.03e-04 | 12 | 62 | 2 | int:TENM2 | |
| Interaction | SPINK4 interactions | 6.03e-04 | 12 | 62 | 2 | int:SPINK4 | |
| Interaction | NUP50 interactions | 6.22e-04 | 341 | 62 | 6 | int:NUP50 | |
| Cytoband | Xq26 | 1.78e-04 | 14 | 65 | 2 | Xq26 | |
| Cytoband | 2q12.3 | 2.65e-04 | 17 | 65 | 2 | 2q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11p15 | 1.24e-03 | 564 | 65 | 5 | chr11p15 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 5.04e-07 | 115 | 47 | 6 | 769 | |
| GeneFamily | Nucleoporins | 7.75e-05 | 32 | 47 | 3 | 1051 | |
| GeneFamily | PWWP domain containing | 1.48e-03 | 22 | 47 | 2 | 1147 | |
| GeneFamily | ETS transcription factor family | 2.39e-03 | 28 | 47 | 2 | 534 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 1.67e-08 | 33 | 64 | 5 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 6.63e-08 | 43 | 64 | 5 | MM3857 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 9.50e-06 | 200 | 64 | 6 | M7771 | |
| Coexpression | SENGUPTA_EBNA1_ANTICORRELATED | 4.68e-05 | 161 | 64 | 5 | M18742 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.69e-06 | 146 | 63 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_200 | 1.85e-05 | 53 | 63 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#1_top-relative-expression-ranked_100 | 2.74e-05 | 20 | 63 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 5.26e-05 | 69 | 63 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_200 | 7.30e-05 | 75 | 63 | 4 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 8.51e-05 | 78 | 63 | 4 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.08e-04 | 369 | 63 | 7 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100 | 1.27e-04 | 33 | 63 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_200 | 1.30e-04 | 165 | 63 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_k-means-cluster#4_top-relative-expression-ranked_500 | 1.76e-04 | 94 | 63 | 4 | gudmap_developingKidney_e15.5_Ureteral Smooth Musc_500_k4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#5_top-relative-expression-ranked_500 | 2.77e-04 | 194 | 63 | 5 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.17e-04 | 311 | 63 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_500 | 3.89e-04 | 209 | 63 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_500_k2 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-06 | 177 | 65 | 5 | c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.08e-06 | 177 | 65 | 5 | 7ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 8.35e-06 | 189 | 65 | 5 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | ASK454-Epithelial-Secretory|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 8.79e-06 | 191 | 65 | 5 | c63c781e7e93265e591cf494cb4ce8ed797c24fb | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.24e-06 | 193 | 65 | 5 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.24e-05 | 162 | 65 | 4 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | 343B-Lymphocytic-ILC|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 166 | 65 | 4 | a54377c703efff42d2cc1a8fdb610facc58053dd | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 1.09e-04 | 169 | 65 | 4 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.11e-04 | 170 | 65 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.14e-04 | 171 | 65 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 171 | 65 | 4 | 0eea035fde32cc2a75a0d4227911edb5d54ed47e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.16e-04 | 172 | 65 | 4 | ebeda7ef181cac0109be750a98e7589c615d2724 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 172 | 65 | 4 | 29c8510f26527d487d0fc3543102d067cdb281a6 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 176 | 65 | 4 | 4ed73c73972334f6dc4229920205547823252fa0 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 176 | 65 | 4 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.42e-04 | 181 | 65 | 4 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.45e-04 | 182 | 65 | 4 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.48e-04 | 183 | 65 | 4 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 1.51e-04 | 184 | 65 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.51e-04 | 184 | 65 | 4 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.54e-04 | 185 | 65 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.54e-04 | 185 | 65 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 188 | 65 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-04 | 188 | 65 | 4 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|Classical_Monocyte / Disease condition and Cell class | 1.67e-04 | 189 | 65 | 4 | 8b6f92ccfffc743c07201bc971b3dc1a6fa14ccc | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 1.71e-04 | 190 | 65 | 4 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.71e-04 | 190 | 65 | 4 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 190 | 65 | 4 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.71e-04 | 190 | 65 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.71e-04 | 190 | 65 | 4 | 05455775845f4ded5c27e7b83242078d23162aaf | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.74e-04 | 191 | 65 | 4 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.74e-04 | 191 | 65 | 4 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.74e-04 | 191 | 65 | 4 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-04 | 192 | 65 | 4 | 445985fe1bcd33e4f0a1704b27988fbfc9334538 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.81e-04 | 193 | 65 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | PSB-critical-LOC-Epithelial-FOXN4+|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.81e-04 | 193 | 65 | 4 | b7d9c5bed524423e92f01496a9f8fad11b33a3f7 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.85e-04 | 194 | 65 | 4 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 195 | 65 | 4 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 195 | 65 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.96e-04 | 197 | 65 | 4 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-04 | 197 | 65 | 4 | b9745e382baa2725dfcae060701fb53f6c8a31fa | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-04 | 197 | 65 | 4 | 5afddde4e2b5cd55abe11e9b9efae02dbdc3da3a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_adipo-stroma-adipo-CAR|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.96e-04 | 197 | 65 | 4 | 1baffd087ca194a7355fefbb3bf67befb14fe2de | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma-adipo-CAR|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-04 | 198 | 65 | 4 | a8c21f4db6730d0aa05b61fbe72bf9f7571a9015 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-04 | 198 | 65 | 4 | 8b68fc887e5ad0a59ea4d93dfd1edda67030f142 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_adipo|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.00e-04 | 198 | 65 | 4 | 4739b2e4ab141c66772e61686b45614a1839483e | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.04e-04 | 199 | 65 | 4 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | a3a1e35934d676c39f917652e50c502cb2f613c1 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 7c62678cf408aaaf98d6df0fb27814d2007c4521 | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; PC3; HT_HG-U133A | 1.39e-06 | 195 | 65 | 7 | 6545_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 1.76e-05 | 191 | 65 | 6 | 2137_UP | |
| Drug | SC-560; Down 200; 10uM; MCF7; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 6913_DN | |
| Drug | Piracetam [7491-74-9]; Up 200; 28.2uM; MCF7; HT_HG-U133A | 1.98e-05 | 195 | 65 | 6 | 2861_UP | |
| Drug | Acetaminophen [103-90-2]; Up 200; 26.4uM; MCF7; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 3364_UP | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; PC3; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 1237_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 7362_UP | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.82e-06 | 12 | 61 | 3 | DOID:9119 (implicated_via_orthology) | |
| Disease | electrocardiography | 1.09e-04 | 530 | 61 | 7 | EFO_0004327 | |
| Disease | Acute erythroleukemia - M6a subtype | 1.17e-04 | 8 | 61 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 1.17e-04 | 8 | 61 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 1.17e-04 | 8 | 61 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 1.17e-04 | 8 | 61 | 2 | C2930974 | |
| Disease | Semantic-Pragmatic Disorder | 2.28e-04 | 11 | 61 | 2 | C0454655 | |
| Disease | Auditory Processing Disorder, Central | 2.28e-04 | 11 | 61 | 2 | C0751257 | |
| Disease | Language Delay | 2.28e-04 | 11 | 61 | 2 | C0023012 | |
| Disease | Language Development Disorders | 2.28e-04 | 11 | 61 | 2 | C0023014 | |
| Disease | Speech Delay | 2.28e-04 | 11 | 61 | 2 | C0241210 | |
| Disease | brain disease (is_implicated_in) | 2.74e-04 | 12 | 61 | 2 | DOID:936 (is_implicated_in) | |
| Disease | alcohol and nicotine codependence | 3.23e-04 | 13 | 61 | 2 | EFO_0004776 | |
| Disease | Leukemia, Myelocytic, Acute | 4.59e-04 | 173 | 61 | 4 | C0023467 | |
| Disease | major depressive disorder (is_implicated_in) | 5.60e-04 | 17 | 61 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | Myeloid Leukemia | 6.30e-04 | 18 | 61 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 6.30e-04 | 18 | 61 | 2 | C0023466 | |
| Disease | initial pursuit acceleration | 7.87e-04 | 87 | 61 | 3 | EFO_0008434 | |
| Disease | pancreatic cancer (is_marker_for) | 1.21e-03 | 101 | 61 | 3 | DOID:1793 (is_marker_for) | |
| Disease | interleukin 5 measurement | 1.53e-03 | 28 | 61 | 2 | EFO_0008185 | |
| Disease | pancreatic cancer (is_implicated_in) | 1.63e-03 | 112 | 61 | 3 | DOID:1793 (is_implicated_in) | |
| Disease | Primary familial dilated cardiomyopathy | 1.76e-03 | 30 | 61 | 2 | cv:C0340427 | |
| Disease | neuroblastoma | 1.80e-03 | 116 | 61 | 3 | EFO_0000621 | |
| Disease | Hyperkinesia, Generalized | 2.00e-03 | 32 | 61 | 2 | C0751217 | |
| Disease | Hyperkinesia | 2.00e-03 | 32 | 61 | 2 | C3887506 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSSSSSSPFKFKLQ | 366 | P50548 | |
| FSPAGLSQDFFSSSL | 451 | P39880 | |
| AKLASFSFLPQSSLS | 276 | P28223 | |
| FSFLPQSSLSSEKLF | 281 | P28223 | |
| FKSSTSASPQGAFSL | 61 | P78314 | |
| GISSVKFSPNTSQFL | 16 | O43684 | |
| IAKSTKSSSLNFSFP | 591 | O60563 | |
| AFQKSSTGFSPETSF | 261 | Q96M86 | |
| SKPFSLFDLSSVGLF | 141 | O00189 | |
| GFNFSFKSALSPSKS | 2266 | P49792 | |
| SNFSFKSALSLSKSP | 1291 | Q99666 | |
| SNFSFKSALSLSKSP | 1291 | O14715 | |
| SSFSSSVPTVKLFIG | 31 | Q02252 | |
| LFLGSSSSVPFTSIF | 156 | Q0GE19 | |
| SSFTAAPTGTTIKFN | 151 | P52948 | |
| TTSLFSKPFGQATTT | 281 | P52948 | |
| SKFTSGAFLSPSVSV | 1051 | P52948 | |
| PASSFFSSALLSIFQ | 131 | O60732 | |
| FSQKFAPGKSTTSIS | 496 | O75112 | |
| STFKDTFTLQASFPL | 451 | Q99607 | |
| STSPQLSTGVSFFFL | 1031 | P15941 | |
| LSSSFTFGGFQVTSK | 246 | P50747 | |
| FFQTIATSIFSTPLS | 1321 | A6NKB5 | |
| LGSSTSSTLSFLFGK | 2021 | A6NKB5 | |
| SSTLSFLFGKRSFSS | 2026 | A6NKB5 | |
| LSNSTSKFPTFLLTG | 11 | A6NGY5 | |
| FSTISSSFSVSPLFN | 301 | P42356 | |
| FSFGSSGFKPTLEST | 546 | P35658 | |
| LFSTTKPLFSSGQFS | 721 | Q8NG31 | |
| SFVTSTNPRKFSGFS | 216 | P49916 | |
| FTDFSTIPSSAFKAA | 81 | Q7Z7J7 | |
| IASKIPSRFFNSSSF | 196 | P28290 | |
| FSKPSSDTFGNSSIS | 356 | O15504 | |
| SKNTDFFPGLSAFLS | 21 | Q8WX93 | |
| SFKTNPCGSISFTTS | 66 | Q9NR21 | |
| LFTSSTPNGSQFLTF | 341 | Q5T0N5 | |
| ATSFFSGKSPVTTLL | 606 | P55265 | |
| PSSTFSKENLIFSVG | 291 | Q6VVX0 | |
| AKGTLPSIFTFSSSV | 1066 | Q6UXX5 | |
| SKIGSFAEPSSVSFS | 2346 | Q03164 | |
| SSDTLFNSPKSLFLG | 1141 | Q9UHC6 | |
| QFGKTSFPTKESFSA | 241 | Q8WXE1 | |
| PFSFTLSGKSRFSGA | 196 | Q1W209 | |
| SVTTSNPSKFTAKFG | 101 | P50461 | |
| LFASSGSFSLQSSIP | 2371 | Q9C0D2 | |
| FKNTLGSAFLTSPIF | 131 | Q8N4W6 | |
| FGSPTTSFLSISKLS | 531 | Q6NUJ5 | |
| TSFLSISKLSPFSEF | 536 | Q6NUJ5 | |
| KSPSFFSKFNILGTV | 306 | Q8NBW4 | |
| KGTTLFSFSLQLPES | 581 | Q9Y2J2 | |
| KIFNSPSNSSTFTGF | 36 | Q8NGC1 | |
| PSNSSTFTGFILLGF | 41 | Q8NGC1 | |
| FNFSFKSALSLSKSP | 1276 | P0DJD0 | |
| SSTSLPTNFSFKGEN | 311 | Q5HYA8 | |
| GAEPELFKTTSFTSF | 66 | Q4G112 | |
| GSNFSFKSALSPSKS | 1291 | Q7Z3J3 | |
| TGSLFGFSFNASLKS | 1566 | Q7Z3J3 | |
| FGSPTTSFLALSQLS | 696 | Q96N64 | |
| SASVFSPSFGLKQTD | 1471 | Q02880 | |
| TEFAKSIPSFSSLFL | 261 | Q03181 | |
| TTGFNFSFKSALSLS | 1281 | P0DJD1 | |
| RHFLFKTSSGSTPLF | 316 | Q9NT68 | |
| LPFDSLNTFRSFGSS | 246 | Q6URK8 | |
| KGNSTALSSLFPSSF | 726 | O60673 | |
| ISPDFSFFNSVSSSK | 71 | P0C7P2 | |
| NFPFSTAVKLSTGCS | 141 | Q8N3Z0 | |
| SSFESVSNVTSFFPK | 901 | Q9P2H5 | |
| FFVFITPFLTKSGSS | 361 | Q8TCT7 | |
| FFPFSNTLLTSSADK | 486 | Q8N0X2 | |
| TFTTATFAATKFGST | 176 | P50616 | |
| QVLFTFNLKSSPSSG | 851 | Q68DK2 | |
| SEPSSTVSLNGTFFK | 966 | Q9UNY4 | |
| GFGSTFKSLFPSSQT | 401 | Q5TIE3 | |
| SPASTASFIFSKGSR | 906 | Q9P206 | |
| SNGRLPFFTNKTLSF | 1726 | Q9NR99 |